| Visualitzacions | |
|---|---|
| In Vivo Viral Control in a HLA-B*35:01 Homozygous Individual after the Vaccine-induced Response to a Well-defined, HIV Gag-derived HLA-B*35 CTL Epitope | 942 |
| octubre 2023 | novembre 2023 | desembre 2023 | gener 2024 | febrer 2024 | març 2024 | abril 2024 | |
|---|---|---|---|---|---|---|---|
| In Vivo Viral Control in a HLA-B*35:01 Homozygous Individual after the Vaccine-induced Response to a Well-defined, HIV Gag-derived HLA-B*35 CTL Epitope | 5 | 3 | 9 | 7 | 2 | 5 | 5 |
| Visualitzacions | |
|---|---|
| artconlli_a2014_brander_christian_vivo_viral_control.pdf | 909 |
| artconlli_a2014_brander_christian_vivo_viral_control.pdf.txt | 5 |
| Visualitzacions | |
|---|---|
| Estats Units | 593 |
| Xina | 68 |
| Rússia | 56 |
| Suècia | 42 |
| Alemanya | 37 |
| França | 32 |
| Ucraïna | 19 |
| Regne Unit | 17 |
| Espanya | 10 |
| Canadà | 7 |
| Visualitzacions | |
|---|---|
| Ashburn | 154 |
| Fairfield | 67 |
| Sunnyvale | 58 |
| Houston | 42 |
| Ann Arbor | 39 |
| Oakland | 29 |
| Zhengzhou | 28 |
| Saint Petersburg | 24 |
| Cambridge | 20 |
| Beijing | 17 |